Stereotaxis Net Profit Margin 2010-2024 | STXS
Stereotaxis net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Stereotaxis Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-12-31 |
$0.03B |
$-0.03B |
-96.30% |
| 2024-09-30 |
$0.03B |
$-0.02B |
-88.46% |
| 2024-06-30 |
$0.03B |
$-0.02B |
-88.00% |
| 2024-03-31 |
$0.03B |
$-0.02B |
-75.00% |
| 2023-12-31 |
$0.03B |
$-0.02B |
-78.57% |
| 2023-09-30 |
$0.03B |
$-0.02B |
-70.00% |
| 2023-06-30 |
$0.03B |
$-0.02B |
-66.67% |
| 2023-03-31 |
$0.03B |
$-0.02B |
-71.43% |
| 2022-12-31 |
$0.03B |
$-0.02B |
-64.29% |
| 2022-09-30 |
$0.03B |
$-0.02B |
-62.07% |
| 2022-06-30 |
$0.03B |
$-0.02B |
-60.00% |
| 2022-03-31 |
$0.03B |
$-0.02B |
-45.45% |
| 2021-12-31 |
$0.04B |
$-0.01B |
-37.14% |
| 2021-09-30 |
$0.03B |
$-0.01B |
-32.35% |
| 2021-06-30 |
$0.03B |
$-0.01B |
-23.53% |
| 2021-03-31 |
$0.03B |
$-0.01B |
-26.67% |
| 2020-12-31 |
$0.03B |
$-0.01B |
-29.63% |
| 2020-09-30 |
$0.03B |
$-0.01B |
-25.93% |
| 2020-06-30 |
$0.03B |
$-0.01B |
-19.23% |
| 2020-03-31 |
$0.03B |
$-0.01B |
-17.86% |
| 2019-12-31 |
$0.03B |
$-0.01B |
-17.24% |
| 2019-09-30 |
$0.03B |
$0.00B |
-13.79% |
| 2019-06-30 |
$0.03B |
$0.00B |
-13.79% |
| 2019-03-31 |
$0.03B |
$0.00B |
-10.00% |
| 2018-12-31 |
$0.03B |
$0.00B |
-3.33% |
| 2018-09-30 |
$0.03B |
$0.00B |
-9.68% |
| 2018-06-30 |
$0.03B |
$-0.01B |
-25.81% |
| 2018-03-31 |
$0.03B |
$-0.01B |
-25.81% |
| 2017-12-31 |
$0.03B |
$-0.01B |
-25.81% |
| 2017-09-30 |
$0.03B |
$0.00B |
-3.33% |
| 2017-06-30 |
$0.03B |
$-0.01B |
-26.67% |
| 2017-03-31 |
$0.03B |
$-0.01B |
-30.00% |
| 2016-12-31 |
$0.03B |
$-0.01B |
-34.38% |
| 2016-09-30 |
$0.03B |
$-0.02B |
-52.94% |
| 2016-06-30 |
$0.04B |
$-0.01B |
-20.00% |
| 2016-03-31 |
$0.04B |
$-0.01B |
-18.92% |
| 2015-12-31 |
$0.04B |
$-0.01B |
-21.05% |
| 2015-09-30 |
$0.04B |
$-0.01B |
-12.82% |
| 2015-06-30 |
$0.04B |
$0.00B |
-10.26% |
| 2015-03-31 |
$0.04B |
$0.00B |
-10.81% |
| 2014-12-31 |
$0.04B |
$-0.01B |
-14.29% |
| 2014-09-30 |
$0.03B |
$-0.01B |
-29.41% |
| 2014-06-30 |
$0.04B |
$-0.07B |
-186.11% |
| 2014-03-31 |
$0.04B |
$-0.07B |
-178.95% |
| 2013-12-31 |
$0.04B |
$-0.07B |
-181.58% |
| 2013-09-30 |
$0.04B |
$-0.07B |
-168.29% |
| 2013-06-30 |
$0.04B |
$-0.01B |
-33.33% |
| 2013-03-31 |
$0.04B |
$-0.01B |
-18.60% |
| 2012-12-31 |
$0.05B |
$-0.01B |
-19.15% |
| 2012-09-30 |
$0.05B |
$-0.01B |
-23.40% |
| 2012-06-30 |
$0.04B |
$-0.02B |
-36.36% |
| 2012-03-31 |
$0.05B |
$-0.03B |
-64.44% |
| 2011-12-31 |
$0.04B |
$-0.03B |
-76.74% |
| 2011-09-30 |
$0.05B |
$-0.03B |
-63.04% |
| 2011-06-30 |
$0.05B |
$-0.03B |
-52.94% |
| 2011-03-31 |
$0.05B |
$-0.02B |
-38.89% |
| 2010-12-31 |
$0.06B |
$-0.02B |
-34.55% |
| 2010-09-30 |
$0.05B |
$-0.02B |
-44.44% |
| 2010-06-30 |
$0.05B |
$-0.03B |
-47.17% |
| 2010-03-31 |
$0.05B |
$-0.03B |
-54.90% |
| 2009-12-31 |
$0.05B |
$-0.03B |
-54.90% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED INSTRUMENTS |
$0.174B |
$0.027B |
|
Stereotaxis designs, manufactures and markets an advanced cardiology instrument control system for use in a hospital's interventional surgical suite to enhance the treatment of coronary artery disease and arrhythmias. The Stereotaxis System is designed to allow physicians to navigate catheters, guidewires and stent delivery devices through the blood vessels and chambers of the heart to treatment sites.
|
